Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12142-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12142-1-AP, RRID:AB_2157076
- Product name
- OIP5 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated OIP5 antibody (Cat. #12142-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IP, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Mitotic Spindle Positioning (MISP) Facilitates Colorectal Cancer Progression by Forming a Complex with Opa Interacting Protein 5 (OIP5) and Activating the JAK2-STAT3 Signaling Pathway.
Engineering redirected NF-κB/OIP5 expression programs to enhance tumor responses to chemotherapy in bladder cancer.
Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancer.
Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation.
Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
Opa-interacting protein 5 modulates docetaxel-induced cell death via regulation of mitophagy in gastric cancer.
OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity.
Mitotic regulator Mis18β interacts with and specifies the centromeric assembly of molecular chaperone holliday junction recognition protein (HJURP).
Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.
Hiura K, Watanabe M, Hirose N, Nakano K, Okamura T, Sasaki H, Sasaki N
International journal of molecular sciences 2024 Mar 6;25(5)
International journal of molecular sciences 2024 Mar 6;25(5)
Engineering redirected NF-κB/OIP5 expression programs to enhance tumor responses to chemotherapy in bladder cancer.
Zheng B, Niu L, Xu H, Yang Y, Chen Y, Wang C, Chen W, Huang W
Science bulletin 2023 Dec 30;68(24):3207-3224
Science bulletin 2023 Dec 30;68(24):3207-3224
Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancer.
Zhu M, Takano A, Tsevegjav B, Yoshitake Y, Shinohara M, Daigo Y
International journal of oncology 2022 Mar;60(3)
International journal of oncology 2022 Mar;60(3)
Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2/JUN/CHEK1/RAC1 dysregulation.
Li Y, Xiao F, Li W, Hu P, Xu R, Li J, Li G, Zhu C
Oncology reports 2019 Apr;41(4):2075-2088
Oncology reports 2019 Apr;41(4):2075-2088
Cancer-testis specific gene OIP5: a downstream gene of E2F1 that promotes tumorigenesis and metastasis in glioblastoma by stabilizing E2F1 signaling.
He J, Zhao Y, Zhao E, Wang X, Dong Z, Chen Y, Yang L, Cui H
Neuro-oncology 2018 Aug 2;20(9):1173-1184
Neuro-oncology 2018 Aug 2;20(9):1173-1184
Opa-interacting protein 5 modulates docetaxel-induced cell death via regulation of mitophagy in gastric cancer.
Kim TW, Lee SJ, Park YJ, Park SY, Oh BM, Park YS, Kim BY, Lee YH, Cho HJ, Yoon SR, Choe YK, Lee HG
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Oct;39(10):1010428317733985
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Oct;39(10):1010428317733985
OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
Li H, Zhang J, Lee MJ, Yu GR, Han X, Kim DG
Oncotarget 2017 Mar 14;8(11):18129-18144
Oncotarget 2017 Mar 14;8(11):18129-18144
Docetaxel-loaded solid lipid nanoparticles suppress breast cancer cells growth with reduced myelosuppression toxicity.
Yuan Q, Han J, Cong W, Ge Y, Ma D, Dai Z, Li Y, Bi X
International journal of nanomedicine 2014;9:4829-46
International journal of nanomedicine 2014;9:4829-46
Mitotic regulator Mis18β interacts with and specifies the centromeric assembly of molecular chaperone holliday junction recognition protein (HJURP).
Wang J, Liu X, Dou Z, Chen L, Jiang H, Fu C, Fu G, Liu D, Zhang J, Zhu T, Fang J, Zang J, Cheng J, Teng M, Ding X, Yao X
The Journal of biological chemistry 2014 Mar 21;289(12):8326-36
The Journal of biological chemistry 2014 Mar 21;289(12):8326-36
Expression of Opa interacting protein 5 (OIP5) is associated with tumor stage and prognosis of clear cell renal cell carcinoma.
Gong M, Xu Y, Dong W, Guo G, Ni W, Wang Y, Wang Y, An R
Acta histochemica 2013 Oct;115(8):810-5
Acta histochemica 2013 Oct;115(8):810-5
Characterization of an Opa interacting protein 5 involved in lung and esophageal carcinogenesis.
Koinuma J, Akiyama H, Fujita M, Hosokawa M, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y
Cancer science 2012 Mar;103(3):577-86
Cancer science 2012 Mar;103(3):577-86
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The OIP5 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human OIP5. This antibody recognizes human, mouse antigen. The OIP5 antibody has been validated for the following applications: ELISA, WB analysis.
